Regulation & Policy
In this section you will find Regulation & Policy market research reports and publications. These provide information on the latest products, news, market growth forecasts, data and business opportunities of value to your organization.
-
Intellectual Property Protection and Regulatory Regimes in Emerging Markets
$3,835.00Published by Business Insights on Dec 14th, 2010The report traces how regulatory policy, in particular relating to intellectual property, has shaped the emerging markets. In doing so, it explores differences in the treatment of generics and innovative... Learn More -
Advances in the Design and Regulation of Adaptive Clinical Trials
$3,835.00Published by Business Insights on Nov 18th, 2010As the pharma industry comes under increasing pressure to replenish revenues which are under threat from generic competition, there is an increased focus on technologies and trial designs which aim... Learn More -
The Medical Device Outlook in Emerging Markets: The role of healthcare and regulatory systems in presenting challenges and growth opportunities
$3,835.00Published by Business Insights on Oct 14th, 2010The emerging economies of Brazil, Russia, India, and China (BRIC) have become lucrative, high-growth markets for medical devices. The device market in developed territories such as the US, Europe... Learn More -
New Approaches to Gaining Market Access for Pharmaceuticals: Pricing & Reimbursement, Policy Development, and the Role of HTAs
$3,835.00Published by Business Insights on Oct 1st, 2010Pharmaceutical costs are in the front line for containing healthcare costs as payors seek to manage constrained budgets while also meeting the healthcare demands of ageing patient populations. Market access... Learn More -
Pharmacovigilance and Other Pharma Regulatory Developments 2010-2020
$2,461.00Published by Visiongain on Sep 9th, 2010What will this decade hold for pharma regulatory affairs? What regulatory demands will pharma companies face from 2010 to 2020? Our new study will show you developments in pharma regulations... Learn More -
Obama's Healthcare Reform Bill and its Impact on the U.S. Healthcare Market
$4,650.00Published by Markets and Markets on Aug 16th, 2010According to World Health Organization, the U.S. healthcare system ranks 37th among the healthcare systems of 200 countries. The U.S. healthcare spending is considered as one of the highest in... Learn More -
Pharmaceutical Anti-counterfeiting Strategies and Commercial Analysis 2010-2020
$2,461.00Published by Visiongain on May 28th, 2010how will the industry and regulators stem the tide of counterfeits? The pharmaceutical anti-counterfeiting market has been generating increasing revenues in recent years, with strong growth to come, as... Learn More -
Impact of Counterfeits on Parallel Trade & Pharmaceutical Distribution: Issues, initiatives and insights for supply chain integrity
$3,835.00Published by Business Insights on Sep 1st, 2009Parallel trade is a legitimate method of pharmaceutical import and export within the EU zone. Although previously recognized in North America as illegal, cross-border reimportation is now permitted following... Learn More -
Emerging Clinical Trial Locations: Market dynamics and the changing healthcare and regulatory environment
$6,710.00Published by Business Insights on Jun 26th, 2009Over the last decade pharmaceutical and biotechnology companies have entered a period where they have become confronted by a variety of complex issues affecting their operational efficiency and profitability. Learn More -
Emerging Clinical Trial Locations - China: Market dynamics and the changing healthcare and regulatory environment
$3,835.00Published by Business Insights on Jun 17th, 2009This report identifies market dynamics and key regulatory changes, and analyzes the implications and factors which need to be taken into consideration when conducting clinical trials in China. Learn More -
Emerging Clinical Trial Locations -Latin America: Market dynamics and the changing healthcare and regulatory environment
$3,835.00Published by Business Insights on Jun 17th, 2009This report identifies market dynamics and key regulatory changes, and analyzes the implications and factors which need to be taken into consideration when conducting clinical trials in Latin America. Learn More -
Emerging Clinical Trial Locations - Eastern Europe: Market dynamics and the changing healthcare and regulatory environment
$3,835.00Published by Business Insights on Jun 17th, 2009Over the last decade pharmaceutical and biotechnology companies have entered a period where they have become confronted by a variety of complex issues affecting their operational efficiency and profitability. Learn More -
Key Trends In Drug-diagnostic Co-development: Identifying collaborative opportunities and navigating regulatory challenges
$3,835.00Published by Business Insights on Jun 1st, 2009Genomic biomarkers are increasingly being used in drug discovery and development programs and are the basis for in vitro diagnostic devices that are used as companion products to specific drugs. Learn More -
Biosimilars and Follow-On Biologics Report: The Global Outlook 2009-2024
$2,461.00Published by Visiongain on Apr 16th, 2009There is great demand for lower-cost biological drugs: commercial and regulatory developments will make biosimilars and follow-on biologics a success - our new report explains how. Learn More -
Pricing and Reimbursement in The United Arab Emirates
$3,800.00Published by Datamonitor on Apr 1st, 2009The healthcare sector in the emirates of Abu Dhabi and Dubai is undergoing drastic changes as a result of the structural and financing reforms that will impact all major actors in the healthcare sector. Learn More
Regulation & Policy
In this section you will find Regulation & Policy market research reports and publications. These provide information on the latest products, news, market growth forecasts, data and business opportunities of value to your organization.
-
Intellectual Property Protection and Regulatory Regimes in Emerging Markets
$3,835.00Published by Business Insights on Dec 14th, 2010The report traces how regulatory policy, in particular relating to intellectual property, has shaped the emerging markets. In doing so, it explores differences in the treatment of generics and innovative... Learn More -
Advances in the Design and Regulation of Adaptive Clinical Trials
$3,835.00Published by Business Insights on Nov 18th, 2010As the pharma industry comes under increasing pressure to replenish revenues which are under threat from generic competition, there is an increased focus on technologies and trial designs which aim... Learn More -
The Medical Device Outlook in Emerging Markets: The role of healthcare and regulatory systems in presenting challenges and growth opportunities
$3,835.00Published by Business Insights on Oct 14th, 2010The emerging economies of Brazil, Russia, India, and China (BRIC) have become lucrative, high-growth markets for medical devices. The device market in developed territories such as the US, Europe... Learn More -
New Approaches to Gaining Market Access for Pharmaceuticals: Pricing & Reimbursement, Policy Development, and the Role of HTAs
$3,835.00Published by Business Insights on Oct 1st, 2010Pharmaceutical costs are in the front line for containing healthcare costs as payors seek to manage constrained budgets while also meeting the healthcare demands of ageing patient populations. Market access... Learn More -
Pharmacovigilance and Other Pharma Regulatory Developments 2010-2020
$2,461.00Published by Visiongain on Sep 9th, 2010What will this decade hold for pharma regulatory affairs? What regulatory demands will pharma companies face from 2010 to 2020? Our new study will show you developments in pharma regulations... Learn More -
Obama's Healthcare Reform Bill and its Impact on the U.S. Healthcare Market
$4,650.00Published by Markets and Markets on Aug 16th, 2010According to World Health Organization, the U.S. healthcare system ranks 37th among the healthcare systems of 200 countries. The U.S. healthcare spending is considered as one of the highest in... Learn More -
Pharmaceutical Anti-counterfeiting Strategies and Commercial Analysis 2010-2020
$2,461.00Published by Visiongain on May 28th, 2010how will the industry and regulators stem the tide of counterfeits? The pharmaceutical anti-counterfeiting market has been generating increasing revenues in recent years, with strong growth to come, as... Learn More -
Impact of Counterfeits on Parallel Trade & Pharmaceutical Distribution: Issues, initiatives and insights for supply chain integrity
$3,835.00Published by Business Insights on Sep 1st, 2009Parallel trade is a legitimate method of pharmaceutical import and export within the EU zone. Although previously recognized in North America as illegal, cross-border reimportation is now permitted following... Learn More -
Emerging Clinical Trial Locations: Market dynamics and the changing healthcare and regulatory environment
$6,710.00Published by Business Insights on Jun 26th, 2009Over the last decade pharmaceutical and biotechnology companies have entered a period where they have become confronted by a variety of complex issues affecting their operational efficiency and profitability. Learn More -
Emerging Clinical Trial Locations - China: Market dynamics and the changing healthcare and regulatory environment
$3,835.00Published by Business Insights on Jun 17th, 2009This report identifies market dynamics and key regulatory changes, and analyzes the implications and factors which need to be taken into consideration when conducting clinical trials in China. Learn More -
Emerging Clinical Trial Locations -Latin America: Market dynamics and the changing healthcare and regulatory environment
$3,835.00Published by Business Insights on Jun 17th, 2009This report identifies market dynamics and key regulatory changes, and analyzes the implications and factors which need to be taken into consideration when conducting clinical trials in Latin America. Learn More -
Emerging Clinical Trial Locations - Eastern Europe: Market dynamics and the changing healthcare and regulatory environment
$3,835.00Published by Business Insights on Jun 17th, 2009Over the last decade pharmaceutical and biotechnology companies have entered a period where they have become confronted by a variety of complex issues affecting their operational efficiency and profitability. Learn More -
Key Trends In Drug-diagnostic Co-development: Identifying collaborative opportunities and navigating regulatory challenges
$3,835.00Published by Business Insights on Jun 1st, 2009Genomic biomarkers are increasingly being used in drug discovery and development programs and are the basis for in vitro diagnostic devices that are used as companion products to specific drugs. Learn More -
Biosimilars and Follow-On Biologics Report: The Global Outlook 2009-2024
$2,461.00Published by Visiongain on Apr 16th, 2009There is great demand for lower-cost biological drugs: commercial and regulatory developments will make biosimilars and follow-on biologics a success - our new report explains how. Learn More -
Pricing and Reimbursement in The United Arab Emirates
$3,800.00Published by Datamonitor on Apr 1st, 2009The healthcare sector in the emirates of Abu Dhabi and Dubai is undergoing drastic changes as a result of the structural and financing reforms that will impact all major actors in the healthcare sector. Learn More